Table 1 Baseline patients characteristics
Characteristics | PC group (n = 34) | VGD group (n = 34) |
|---|---|---|
Age, years | Â | Â |
   Median | 66 | 64 |
   Range | (33-75) | (39-79) |
Sex, n (%) | Â | Â |
   Male | 19 (56%) | 28 (82%) |
   Female | 15 (44%) | 6 (18%) |
ECOG performance status, n (%) | Â | Â |
   0 | 12 (35%) | 15 (44%) |
   1 | 22 (65%) | 19 (56%) |
Histologic type, n (%) | Â | Â |
   Adenocarcinoma | 26 (76%) | 22 (65%) |
   Squamous cell | 5 (15%) | 9 (26%) |
   Other | 3 (9%) | 3 (9%) |
Stage, n (%) | Â | Â |
   IIIB | 3 (9%) | 4 (12%) |
   IV | 31 (91%) | 30 (88%) |
Weight loss (from 6 months before enrolment, n (%) | Â | Â |
   <5% | 29 (85%) | 31 (91%) |
   ≥5% | 5 (15%) | 3 (9%) |
LDH concentration, n (%) | Â | Â |
   Normal | 28 (82%) | 28 (82%) |
   Abnormal | 6 (18%) | 6 (18%) |